| Microneedles for transdermal drug delivery: a systematic review S Dharadhar, A Majumdar, S Dhoble, V Patravale Drug development and industrial pharmacy 45 (2), 188-201, 2019 | 112 | 2019 |
| Development of anti-angiogenic erlotinib liposomal formulation for pulmonary hypertension: a QbD approach S Dhoble, V Patravale Drug delivery and translational research 9, 980-996, 2019 | 24 | 2019 |
| Transmucosal nanoparticles: toxicological overview S Talkar, S Dhoble, A Majumdar, V Patravale Cellular and molecular toxicology of nanoparticles, 37-57, 2018 | 19 | 2018 |
| Effect of various anticoagulants on the bioanalysis of drugs in rat blood: implication for pharmacokinetic studies of anticancer drugs P Kulkarni, A Karanam, M Gurjar, S Dhoble, AB Naik, BH Vidhun, V Gota Springerplus 5, 1-8, 2016 | 18 | 2016 |
| A triple combination'nano'dry powder inhaler for tuberculosis: in vitro and in vivo pulmonary characterization MM Chogale, SB Dhoble, VB Patravale Drug delivery and translational research 11 (4), 1520-1531, 2021 | 14 | 2021 |
| Comprehensive review on novel targets and emerging therapeutic modalities for pulmonary arterial Hypertension S Dhoble, V Patravale, E Weaver, DA Lamprou, T Patravale International Journal of Pharmaceutics 621, 121792, 2022 | 13 | 2022 |
| Xyloglucan based mucosal nanovaccine for immunological protection against brucellosis developed by supercritical fluid technology S Vyas, S Dhoble, V Ghodake, V Patravale International Journal of Pharmaceutics: X 2, 100053, 2020 | 10 | 2020 |
| Detoxification of Abrus precatorius L. seeds by Ayurvedic Shodhana process and anti-inflammatory potential of the detoxified extract SB Dhoble, AS Majumdar Journal of Ayurveda and Integrative Medicine 5 (3), 154, 2014 | 7 | 2014 |
| Site-specific delivery of inhalable antiangiogenic liposomal dry powder inhaler technology ameliorates experimental pulmonary hypertension S Dhoble, V Ghodake, V Peshattiwar, V Patravale Journal of Drug Delivery Science and Technology 62, 102396, 2021 | 4 | 2021 |
| SIRT 1 activator loaded inhaled antiangiogenic liposomal formulation development for pulmonary hypertension S Dhoble, V Patravale AAPS PharmSciTech 23 (5), 158, 2022 | 3 | 2022 |
| Nanoformulations for the therapy of pulmonary infections S Dhoble, V Ghodake, M Chogale, V Patravale Nanostructures for Antimicrobial Therapy, 457-480, 2017 | 2 | 2017 |
| Opportunities and Challenges in Targeted Carrier-Based Intracellular Drug Delivery: Increased Efficacy and Reduced Toxicity S Dhoble, S Dhage, S Pulakkat, VB Patravale Novel Drug Delivery Technologies: Innovative Strategies for Drug Re …, 2019 | 1 | 2019 |
| Anti-biofilm potential against P. aeruginosa biofilm in cystic fibrosis infection by systemically developed garlic extract incorporated liposomal formulation V Ghodake, S Dhoble, SL Vavilala, V Patravale Journal of Drug Delivery Science and Technology 82, 104359, 2023 | | 2023 |
| Safe Subunit Green Vaccines Confer Robust Immunity and Protection against Mucosal Brucella Infection in Mice MF Abushahba, AS Dadelahi, EL Lemoine, JA Skyberg, S Vyas, S Dhoble, ... Vaccines 11 (3), 546, 2023 | | 2023 |
| Nanoformulations for the Therapy of Pulmonary Infections VP Sagar DHoble, Vinod Ghodake, Manasi Chogale Nanostructures for Antimicrobial Therapy, 0 | | |
Vandana PatravaleProfessor of pharmaceutics, ICT在 ictmumbai.edu.in 的电子邮件经过验证
